|
Model Number 9004 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Reocclusion (1985); Claudication (2550)
|
Event Date 02/01/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
Analysis: the sample was not returned from the user facility; therefore, a device evaluation is unable to be performed.A lot history review revealed 1 additional reocclusion complaint was associated with this lot.A review of the device history record (dhr) indicates the lot was manufactured to specification.Conclusion: the actual sample was not received for evaluation.The dhr found nothing to indicate a manufacturing related cause for this event.Reportedly, the patient had a reintervention involving the target lesion and additional vessels on (b)(6) 2016, but it is unknown what treatment was performed.A target lesion reintervention was performed on (b)(6) 2017, reportedly after the patient experienced lifestyle limiting claudication.The investigator assessed that the lifestyle limiting claudication was possibly related to the study device used during the index procedure as well as the index procedure.Based on the instructions for use (ifu), the occurrence of reocclusion and claudication are inherent risks of any pta procedure.If additional information becomes known to the manufacturer, a supplemental report will be provided with all relevant information.
|
|
Event Description
|
It was reported through a clinical registry that during the index procedure, a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter was used to treat the target lesion located in the right distal superficial femoral artery (sfa).Approximately 6 months after the index procedure, the patient allegedly experienced lifestyle limiting claudication at the target limb due to the reocclusion of the target lesion and vessel.Reportedly, the patient had a reintervention involving the target lesion and additional vessels on (b)(6) 2016, but it is unknown what treatment was performed.A target lesion reintervention was performed on (b)(6) 2017, reportedly after the patient experienced lifestyle limiting claudication.The investigator assessed that the lifestyle limiting claudication was possibly related to the study device used during the index procedure as well as the index procedure.The sample was discarded by the user facility and is not available for further evaluation.No adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|